propargylamine derivatives (University of Barcelona/Consejo Superior De Investigaciones Cientificas/Universitat Autonoma de Barcelona)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepropargylamine derivatives (University of Barcelona/Consejo Superior De Investigaciones Cientificas/Universitat Autonoma de Barcelona)

Drug Alias Namemonoamine oxidases A and B/acetylcholinesterase/butyrylcholinesterase inhibitors (University of Barcelona/Consejo Superior De Investigaciones Cientificas/Universitat Autonoma de Barcelona)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAcetylcholinesterase inhibitorsMonoamine oxidase B inhibitorsMonoamine oxidase A inhibitors

TargetsMonoamine oxidase BAcetylcholinesteraseMonoamine oxidase A

Therapy Area/IndicationsNerve Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversitat De Barcelona

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversitat Autonoma De Barcelona Universitat De Barcelona Spanish National Research Council

Active IndicationsN/A

Inactive IndicationsNerve Degeneration

Other Information

ATC CodeN/A